Northwestern Medicine scientists have developed a new way to image chromatin within living cells, opening the door to large-scale screening techniques, including for cancer.
Northwestern Medicine scientists identified an enzyme as a potential new target for triple-negative breast cancer, a form of breast cancer that is associated with early tumor recurrence and significantly increased mortality rates.
Research from McCormick School of Engineering and Northwestern Medicine scientists describes new MRI technique that can detect blood flow velocity to identify who is most at risk for stroke.
Northwestern Medicine scientists have discovered circadian clocks in muscle tissue that control the muscle’s metabolic response and energy efficiency depending on the time of day.
A new pathway in the brain can be manipulated to alleviate depression, offering a promising new target for developing a drug that could be effective in individuals for whom other antidepressants have failed.
Feinberg faculty, students and staff gathered to celebrate and advance medical education through workshops, lectures and presentations at the 6th Annual Medical Education Day.
Northwestern’s biomaterials labs are developing the next generation of materials in medicine, called supramolecular biomaterials – molecules designed in a way to mimic cell structures and functions of biological signaling.
At Driskill day, students, faculty members and alumni celebrated accomplishments and research occurring in the Driskill Graduate Program in Life Sciences.
National Institutes of Health Director Francis Collins and Illinois Sen. Dick Durbin spoke to an auditorium of nearly 300 physicians and researchers at Northwestern about the critical importance of sustaining momentum in medical research funding.
Analyzing a patient’s own stem cells can predict the safety and efficacy of drugs that have the potential to damage a patient’s heart, according to a new study.